Shanghai Hansoh Biomedical Co., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shanghai Hansoh Biomedical Co., LTD..The latest application filed is for "egfr inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application".

Company Profile

11.9.21

Shanghai Hansoh Biomedical Co., LTD. - Shanghai CN
Shanghai Hansoh Biomedical Co., Ltd. - Zhangjiang Hi-Tech Park, Shanghai N/A CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application App 20220281847 - Chen; Zhongke ; et al.	2022-09-08
Salt And Crystal Form Of Steroid Derivative Regulator App 20220275020 - LI; Zongbin ; et al.	2022-09-01
Inhibitor Containing Bicyclic Derivative, Preparation Method Therefor And Use Thereof App 20220259201 - SU; Yidong ; et al.	2022-08-18
Anti-bcma Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof App 20220251228 - HUA; Haiqing ; et al.	2022-08-11
Nitrogen-containing Heterocyclic Derivative Regulator, Preparation Method Therefor And Application Thereof App 20220213100 - LIU; Shiqiang ; et al.	2022-07-07
Multi-receptor Agonist And Medical Use Thereof App 20220168396 - WU; Fangzhou ; et al.	2022-06-02
Fgfr4 Inhibitor And Preparation Method And Use Thereof App 20220024913 - GAO; Peng ; et al.	2022-01-27
Steroid Derivative Regulators, Method For Preparing The Same, And Uses Thereof App 20220017565 - SU; Yidong ; et al.	2022-01-20
Regulator Of Nitrogen-containing Heteroaromatic Derivatives, Preparation Method Therefor And Use Thereof App 20210355105 - Liu; Shiqiang ; et al.	2021-11-18
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application Grant 11,155,534 - Chen , et al. October 26, 2	2021-10-26
Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors Grant 11,136,324 - Gao , et al. October 5, 2	2021-10-05
Tricyclic Derivatives Inhibitor, Preparation Method, And Applications Thereof App 20210221822 - Gao; Peng ; et al.	2021-07-22
Steroid Derivative Regulators, Method For Preparing The Same, And Uses Thereof App 20210139530 - SU; Yidong ; et al.	2021-05-13
Amide Derivative Inhibitor And Preparation Method And Application Thereof App 20210032249 - GAO; Peng ; et al.	2021-02-04
Anti-b7-h4 Antibody, Antigen-binding Fragment Thereof And Pharmaceutical Use Thereof App 20210032347 - BAO; Rudi ; et al.	2021-02-04
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application App 20200361909 - CHEN; Zhongke ; et al.	2020-11-19
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application Grant 10,759,782 - Chen , et al. Sep	2020-09-01
Pyrazolyl-containing Tricyclic Derivative, Preparation Method Therefor And Use Thereof App 20200247815A1 -	2020-08-06
EGFR inhibitor, preparation method and use thereof Grant 10,428,081 - Wei , et al. October 1, 2	2019-10-01
Fgfr4 Inhibitor, Preparation Method Therefor, And Applications Thereof App 20190276451 - GAO; Peng ; et al.	2019-09-12
EGFR inhibitor, preparation method and use thereof Grant 10,259,820 - Wei , et al.	2019-04-16
Egfr Inhibitor, Preparation Method And Use Thereof App 20190100528 - WEI; Mingsong ; et al.	2019-04-04
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application App 20190077791 - CHEN; Zhongke ; et al.	2019-03-14
Indoleamine 2,3-dioxygenase Inhibitor, Preparation Method Therefor, And Application App 20190040025 - WU; Shenghua ; et al.	2019-02-07
Cholic Acid Derivative, And Preparation Method And Medical Use Thereof App 20180148470 - LI; Chenghai ; et al.	2018-05-31
Egfr Inhibitor, Preparation Method And Use Thereof App 20170313714 - WEI; Mingsong ; et al.	2017-11-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.